266 related articles for article (PubMed ID: 19081465)
1. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience.
Mearini L; D'Urso L; Collura D; Zucchi A; Costantini E; Formiconi A; Bini V; Muto G; Porena M
J Urol; 2009 Jan; 181(1):105-11; discussion 111-2. PubMed ID: 19081465
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
[TBL] [Abstract][Full Text] [Related]
3. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience.
Uchida T; Shoji S; Nakano M; Hongo S; Nitta M; Murota A; Nagata Y
Int J Urol; 2009 Nov; 16(11):881-6. PubMed ID: 19863624
[TBL] [Abstract][Full Text] [Related]
4. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
[TBL] [Abstract][Full Text] [Related]
5. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
[TBL] [Abstract][Full Text] [Related]
6. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
[TBL] [Abstract][Full Text] [Related]
7. Treatment of localized prostate cancer using high-intensity focused ultrasound.
Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
[TBL] [Abstract][Full Text] [Related]
8. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.
Lawrentschuk N; Finelli A; Van der Kwast TH; Ryan P; Bolton DM; Fleshner NE; Trachtenberg J; Klotz L; Robinette M; Woo H
J Urol; 2011 Mar; 185(3):862-8. PubMed ID: 21239003
[TBL] [Abstract][Full Text] [Related]
9. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
10. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
11. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
12. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
13. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
[TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
16. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
17. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
[TBL] [Abstract][Full Text] [Related]
18. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
19. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
20. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]